Advances in molecular diagnosis of inherited hemoglobin disorders

Current Opinion in Hematology

Volumn 3, Issue 2, 1996, Pages 131-138

  Sutcharitchan, Pranee ^a   Embury, Stephen H ^b,c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEMOGLOBIN;

ALLELE; DNA HYBRIDIZATION; DNA SEQUENCE; DOT HYBRIDIZATION; ELECTROPHORETIC MOBILITY; FETUS; GENETIC SCREENING; HEMOGLOBINOPATHY; HUMAN; MOLECULAR GENETICS; MUTATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESTRICTION MAPPING; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 0029888998     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603020-00005     Document Type: Review

References (97)

1. Embury SH: Prenatal diagnosis. In Sickle Cell Disease: Basic Principles and Clinical Practice. Edited by Embury SH, Hebbel RP, Mohandas N, Steinberg MH. New York: Raven Press; 1994:485-503. A comprehensive review of social, ethical, and legal aspects of prenatal diagnosis, fetal sampling methodology, and DNA diagnostics. This discussion deals in some detail with social and ethical issues and the development of fetal sampling techniques.
2. Kazazian HHJR, Boehm CD: Molecular basis and prenatal diagnosis of p-thalassemia. Blood 1988, 72:1107-1116.
3. Powledge TM, Fletcher J: Guidelines for the ethical, social and legal issues in prenatal diagnosis. N Engl J Med 1979, 300:168-172.
4. Gates EA: Ethical considerations in prenatal diagnosis. West J Med 1993, 159:391-395.
5. Hollowed EE, Eldridge JE: The legal implications of current and future prenatal diagnostic and therapeutic techniques. In Human Prenatal Diagnosis. Edited by Filkins K, Russo JF. New York: Marcel Dekker, Inc.; 1990:533-546.
6. Boehm C, Kazazian HH JR: Prenatal diagnosis of hemoglobinopathies by DNA analysis. Crit Rev Oncol Hematol 1993, 4:155-167.
7. Filkins K, Russo JF: Human Prenatal Diagnosis, edn 2. New York: Marcel Dekker; 1990.
8. Goldberg JD, ed: Fetal medicine. West J Med 1993, 159:259-407.
9. Evans Ml, Johnson MP, eds: Prenatal diagnosis in the 90's. J Reprod Med 1992, 37:387-444.
10. Wang BBT, Rubin CH, Williams J III: Mosaicism in chorionic villus sampling: an analysis of incidence and chromosomes involved in 2612 consecutive cases. Prenat Diagn 1993, 13:179-190.
11. Mastroiacovo P, Botto LD, Cavalcanti DP, Lalatta F, Selicorni A, Tozzi AE, Baronciani D, Cigolotti AC, Giordano S, Petroni F, Puppin F: Limb anomalies following chorionic villus sampling: a registry-based case control study. Am J Med Genet 1992, 44:856-864.
12. Price JO, Elias S, Wachtel SS, Klinger K, Dockter M, Tharapel A, Shulman LP, Phillips OP, Meyers CM, Shook D: Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 1991, 165:1731-1737.
13. Embury SH: Advances in the prenatal and molecular diagnosis of the hemoglobinopathies and thalassemias. Hemoglobin 1995, 19:237-261. A review of ethical and social aspects of prenatal diagnosis, fetal sampling methods, and molecular diagnostic approaches.
14. Kan YW, Dozy AM: Polymorphism of DNA sequence adjacent to human β-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A 1978, 75:5631-5635.
15. Geever RF, Wilson LB, Nallaseth FS, Milner PF, Bittner M, Wilson JT: Direct identification of sickle cell anemia by blot hybridization. Proc Natl Acad Sci U S A 1981, 78:5081-5085.
16. s-globin allele by hybridization with synthetic oligonucleotides. Proc Natl Acad Sci U S A 1983, 80:278-282.
17. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985, 230:1350-1354.
18. Kan YW, Dozy AM: Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic-fluid cells. Lancet 1978, 2:910-912.
19. Orkin SH, Little PFR, Kazazian HH, Boehm CD: Improved detection of the sickle mutation by DNA analysis: application to prenatal diagnosis. N Engl J Med 1982, 307:32-36.
20. Chang JC, Kan YW: A sensitive new prenatal test for sickle-cell anemia. N Engl J Med 1982, 307:30-32.
21. Gosden CM: Amniotic fluid cell types culture. Br Med Bull 1983, 39:348-354.
22. Dong JH, Xu SD, Lu FQ, Huang SZ, Huang Y, Gu LQ, Zeng ZT: A modified method of amniocentesis. Shanghai Med J 1985, 8:599-600.
23. Li H, Gyllensten UB, Cui X, Saiki RK, Erlich HA, Amheim N: Amplification analysis of DNA sequences in single human sperm and diploid cells. Nature 1988, 335:414-417.
24. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988, 239:487-491.
25. Embury SH, Scharf SJ, Saiki RK, Gholson MA, Golbus M, Arnheim N, Erlich HA: Rapid prenatal diagnosis of sickle cell anemia by a new method of DNA analysis. N Engl J Med 1987, 316:656-661.
26. Chehab FF, Doherty M, Cai S, Kan YW, Cooper S, Rubin EM: Detection of sickle cell anaemia and thalassaemias. Nature 1987, 329:293-294.
27. o-thalassemia by hemoglobin E mutation analysis. J Pediatr 1992, 120:775-779.
28. Plaseska D, Koceva S, Rasovic N, Efremov GD: Hb Volga[β27(B9)Ala→Asp]: detection of a de novo mutation by Ava II digestion of pre-amplified DNA. Hemoglobin 1993, 17:209-215.
29. Williamson D, Perry DJ, Brown K, Langdown JV: Compound heterozygosity for two b chain variants: Hb S [β6(A3)Glu→Val] and the high affinity variant Hb San Diego [β109(G11)Val→Met]. Hemoglobin 1995, 19:27-32.
30. Akar N, Ozden A, Akar E, Cin S, Arcasoy A: Discrimination of Hb D Los Angeles (B21 Glu-Gln) and Hb Beograd (B21 Glu-Val) by dual restriction enzyme analysis. Am J Hematol 1995, 48:280-281.
31. Tamagnini GP, Goncalves P, Ribeiro MLS, Kaeda J, Kutlar F, Baysal E, Huisman THJ: β-thalassemia mutations in the Portugese: high frequencies of two alleles in restricted populations. Hemoglobin 1993, 17:31-40.
32. Chang J-G, Chiou S-S, Perng L-I, Chen T-C, Liu T-C, Lee L-S, Chen P-H, Tang TK: Molecular characterization of glucose-6-phosphate dydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan. Blood 1992, 80:1079-1082.
33. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A: Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 1989, 17:3606.
34. Lindeman R, Hu SP, Valpato F, Trent RJ: Polymerase chain reaction mutagenesis enabling rapid non-radioactive detection of common β-thalassaemia mutations in Mediterraneans. Br J Haematol 1991, 78:100-104.
35. 29(A6) Ser→Cys] in a Brazilian female. Hemoglobin 1994, 18:235-239.
36. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA: Analysis of enzymatically amplified β-globin HLA-DQα DNA with allele-specific oligonucleotide probes. Nature 1986, 324:163-166.
37. Saiki RK, Chang C-A, Levenson CH, Warren TC, Boehm CD, Kazazian HH, Erlich HA: Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 1988, 319:537-541.
38. Gonzalez-Redondo JM, Kutlar A, Kutlar F, McKie KM, Baysal E, Huisman THJ: Molecular characterization of Hb S(C) β-thalassemia in American Blacks. Am J Hematol 1991, 38:9-14.
39. El-Kalla S, Matthews AR: A novel frameshift mutation causing β-thalassemia in a Sikh. Hemoglobin 1995, 19:183-189.
40. Merat A, Haghshenas M, Mostafavi Pour Z, Plonczynski MW, Harrell AN, Coleman MB, Steinberg MH: β-Thalassemia in southwestern Iran. Hemoglobin 1993, 17:427-437.
41. Li H-J, Yu W-Z, Zhou C-W, Hao X-J, Zhou Y: The β-thalassemia frameshift at codon 8 (-AA) observed in four Chinese of the Uygur nationality. Hemoglobin 1993, 17:537-541.
42. Basak AN, Ozer A, Kirdar B, Akar N: A novel 13 bp deletion in the 3'UTR of the β-globin gene causes β-thalassemia in a Turkish patient. Hemoglobin 1993, 17:551-555.
43. Jiang NH, Liang S, Su C, Nechtman JF, Stoming TA: A novel β-thalassemia mutation [IVS-II-5 (G→C) in a Chinese family from Guangxi province, P.R. China. Hemoglobin 1993, 17:563-567.
44. Sadiq MFG, Huisman THJ: Molecular characterization of β-thalassemia in north Jordan. Hemoglobin 1994, 18:325-332.
45. Hsia YE, Ford CA, Shapiro U, Hunt JA, Ching NSP: Molecular screening for haemoglobin Constant Spring. Lancet 1989, 1:988-991.
46. Kropp GL, Fucharoen S, Embury SH: Selective enzymatic amplification of α2-globin DNA for detection of the hemoglobin Constant Spring mutation. Blood 1989, 73:1987-1992.
47. 2115(G17)Ala→Asp, a severely unstable hemoglobin variant resulting in a dominant β-thalassemia trait in a Czech family. Hemoglobin 1993, 17:319-328.
48. 268(E12)Leu→Pro in a young Dutch boy. Hemoglobin 1995, 19:203-206.
49. 231(B13)Leu→Arg, a severely unstable hemoglobin variant associated with numerous intraerythroblastic inclusions and erythroid hyperplasia of the bone marrow. Hemoglobin 1995, 19:165-172.
50. 2 in a Caucasian family from Alabama. Hemoglobin 1995, 19:151-164.
51. Saiki RK, Walsh PS, Levenson CH, Erlich HA: Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A 1989, 86:6230-6234.
52. Kawasaki E, Saiki R, Erlich H: Genetic analysis using polymerase chain reaction-amplified DNA and immobilized oligonucieotide probes: reverse dot blot typing. Methods Enzymol 1993, 218:369-381.
53. Sutcharitchan P, Saiki R, Fucharoen S, Winichagoon P, Erlich H, Embury SH: Reverse dot-blot detection of Thai β-thalassaemia mutations. Br J Haematol 1995, 90:809-816. A description of the application of this PCR-based method of screening with a single hybridization reaction for the several β-thalassemia alleles of the Thai population plus hemoglobin E. This approach provides a useful method for prenatal diagnosis, routine clinical screening, and population screening.
54. Sutcharitchan P, Saiki R, Huisman THJ, Kutlar A, McKie V, Erlich H, Embury SH: Reverse dot-blot detection of the African-American β-thalassemia mutations. Blood 1995, 86:1580-1585. A description of the application of this PCR-based method of screening for several mutant alleles in a single hybridization reaction. This report describes the application of reverse dot blotting to the β-thalassemia mutations of blacks plus hemoglobin S and hemoglobin C. It has utility for prenatal and clinical diagnosis and for population screening.
55. Maggio A, Giambona A, Cai S-P, Wall J, Kan YW, Chehab C: Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean β-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood 1993, 81:239-242.
56. Cai S-P, Wall J, Kan YW, Chehab FF: Reverse dot blot probes for the screening of β-thalassemia in Asians and American Blacks. Hum Mutat 1994, 3:59-63.
57. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF: Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res 1989, 17:2503-2516.
58. Postnikov YUV, Molchanova TP, Huisman THJ: Allele-specific amplification for the identification of several hemoglobin variants. Hemoglobin 1993, 17:439-452.
59. Gibbs RA, Nguyen P-N, Caskey CT: Detection of single DNA base differences by competitive oligonucleotide priming. Nucleic Acids Res 1989, 17:2437-2448.
60. Fucharoen S, Fucharoen G, Fukumaki Y: Simple non-radioactive method for detecting haemoglobin Constant Spring gene. Lancet 1990, 335:1527.
61. Fsichel-Ghodsian N, Hirsch PC, Bohlman MC: Rapid detection of the hemoglobin C mutation by allele-specific polymerase chain reaction. Am J Hum Genet 1990, 47:1023-1024.
62. Pagano L, Desicato S, Viola A, De Rosa C, Fioretti G: Identification of the -92 (C→T) mutation by the amplification refractory mutation system in southern Italy. Hemoglobin 1995, 19:307-310.
63. Chehab FF, Kan YW: Detection of sickle cell anaemia mutation by colour DNA amplification. Lancet 1990, 335:15-17.
64. Chehab FF, Kan YW: Detection of specific DNA sequences by fluorescence amplification: a color complementation assay. Proc Natl Acad Sci U S A 1989, 86:9178-9182.
65. Embury SH, Kropp GL, Stanton TS, Cornett PA, Chehab FF: Detection of the hemoglobin E mutation using the color complementation assay: application to complex genotyping. Blood 1990, 76:619-623.
66. Kropp GL, Cornett PA, Leavitt AD, Reardon TP, Embury SH: Resolution of complex genotypes containing hemoglobin C genes using the allele-specific fluorescence polymerase chain reaction [abstract]. Blood 1990, 76(suppl 1):257a.
67. Kropp GL, Fucharoen S, Embury SH: Asymmetrically primed selective amplification/temperature shift fluorescence polymerase chain reaction to detect the hemoglobin Constant Spring mutation. Blood 1991, 78:26-29.
68. Chu BM, Hsia YE, Hunt JA, Yuen J: Gap PCR for rapid detection of single alpha-globin gene deletions [abstract]. Am J Hum Genet 1991, 46:184a.
69. Camaschella C, Alfarano A, Gottardi E, Travi M, Primignani P, Cappio FC, Saglio G: Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood. Blood 1990, 75:2102-2106.
70. Goncalves MS, Fahel S, Figueiredo MS, Kimura EJ, Nechtman F, Stoming TA, Arruda VR, Saad STO, Costa FF: Molecular Identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from Brazil. Ann Hematol 1995, 70:159-161. A report of the molecular lesion in an individual found to have the hereditary persistence of fetal hemoglobin type 2 deletion. This analysis used a combination of PCR-based methods.
71. Craig JE, Barnetson RA, Prior J, Raven JL, Thein SL: Rapid detection of deletions causing δβ thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood 1994, 83:1673-1682. A comprehensive description of the methodology and primers necessary to detect this important group of deletions that cause an interrelated set of diseases. This thorough description provides excellent methodological detail.
72. Martinez G, Hernandez A, Corral L, Muniz A, Alaez C, Serra A, Alfarano A, Saglio G, Camaschella C: Molecular characteristics of hereditary persistence of fetal hemoglobin in a patient from Cuba. Blood 1990, 79:1262-1263.
73. Lebo RV, Saiki RK, Swanson K, Montano MA, Erlich HA, Golbus MS: Prenatal diagnosis of α-thalassemia by polymerase chain reaction and dual restriction enzyme analysis. Hum Genet 1990, 85:293-299.
74. anti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 1992, 82:105-111.
75. Baysal E, Huisman THJ: Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994, 46:208-213. A description of Gap PCR to diagnose some of the common deletions responsi-ble for α-thalassemia. These deletions reside in highly homologous duplicated sequences, which provide a particular challenge to allele-specific amplification. Although this method overcame significant technological difficulties, its utilization requires separate PCR primers and exacting reaction conditions for each deletion sought. Many laboratories prefer to use Southern blotting, which has the capacity to detect several deletions in a single reaction.
76. Embury SH, Miller JA, Dozy AM, Kan YW, Chan Y, Todd D: Two different molecular organizations account for the single α-globin gene in the α-thalassemia genotype. J Clin Invest 1980, 66:1319-1325.
77. Goossens M, Dozy AM, Embury SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW: Triplicated α-globin loci in humans. Proc Natl Acad Sci U S A 1980, 77:518-521.
78. Lie-Injo LE, Herrera AR, Kan YW: Two types of triplicated α-globin loci in humans. Nucleic Acids Res 1981, 9:3707-3717.
79. Kuppuswamy MN, Hoffman JW, Kasper CK, Sptizer SG, Groce SL, Bajaj SP: Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci U S A 1991, 88:1143-1147.
80. Barany F: Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A 1991, 88:189-193.
81. Barany F: The ligase chain reaction in a PCR world. PCR Methods Appl 1991, 1:5-16.
82. Walker GT, Little MC, Nadeau JG, Shank DD: Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. Proc Natl Acad Sci U S A 1992, 89:392-396.
83. Walker GT, Fraiser MS, Schram JL, Little MC, Nadeau JG, Malinowski DP: Strand displacement amplification: an isothermal, in vitro DNA amplification technique. Nucleic Acids Res 1992, 20:1691-1696.
84. Fischer SG, Lerman LS: DNA fragments differing by single base-pair substitution are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci U S A 1983, 80:1579-1583.
85. Wartell RM, Hosseini SH, Moran CP: Detecting base pair substitutions in DNA fragments by temperature-gradient gel electrophoresis. Nucleic Acids Res 1990, 18:2699-2705.
86. Sheffield VC, Cox DR, Lerman LS, Myers RM: Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A 1989, 86:232-236.
87. Cai S-P, Kan YW: Identification of the multiple β-thalassemia mutations by denaturing gradient gel electrophoresis. J Clin Invest 1990, 85:550-553.
88. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989, 86:2766-2770.
89. Hayashi K: PCR-SSCP: a simple sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991, 1:34-38.
90. Craig JE, Sheerin SM, Barnetson R, Them SL: The molecular basis of HPFH in a British family identified by heteroduplex formation. Br J Haematol 1993, 84:106-110.
91. Triggs-Raine BL, Gravel RA: Diagnostic heteroduplexes: simple detection of carriers of a 4 bp insertion mutation in Tay-Sachs disease. Am J Hum Genet 1990, 46:183-184.
92. Wood N, Standen G, Hows J, Bradley B, Bidwell J: Diagnosis of sickle-cell disease with a universal heteroduplex generator. Lancet 1993, 342:1519-1520.
93. Savage DA, Wood NAP, Bidwell JL, Fitches A, Old JM, Hui KM: Detection of β-thalassaemia mutations using DNA heteroduplex generator molecules. Br J Haematol 1995, 90:564-571. This report describes the application of a clever, PCR-based electrophoretic method to detecting β-thalassemia mutations. It can be applied to detecting more than a single mutation in one reaction.
94. Wong C, Dowling CE, Saiki RK, Higuchi RG, Erlich HA, Kazazian HH: Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature 1987, 339:394-386.
95. Gyllensten UB, Erlich HA: Generation of single-stranded DNA by the polymerase chain reaction its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A 1988, 85:7652-7656.
96. Engelke DR, Hoener PA, Collins FS: Direct sequencing of enzymatically amplified human genomic DNA. Proc Natl Acad Sci U S A 1988, 85:544-548.
97. Innis MA, Myambo KB, Gelfand DH, Brow MAD: DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci U S A 1988, 85:9436-9440.